Human cytomegalovirus is a herpes virus with poorly understood transmission 2 dynamics. We here provide quantitative estimates of the transmissibility of primary 3 infection, reactivation, and re-infection using age-and sex-specific antibody response 4 data. The data are optimally described by three distributions of antibody 5 measurements, i.e. uninfected, infected, and infected after reactivation/re-infection. 6 Estimates of seroprevalence increase gradually with age, such that at 80 years 73% 7 (95%CrI: 64%-78%) of females and 62% (95%CrI: 55%-68%) of males is infected, while 8 57% (95%CrI: 47%-67%) of females and 37% (95%CrI: 28%-46%) of males has 9 experienced a reactivation or re-infection episode. Merging the statistical analyses with 10 transmission models, we find that infectious reactivation is key to provide a good fit fit 11 to the data. Estimated reactivation rates increase from low values in children to 2%-6% 12 1 per year older women. The results advance a hypothesis in which adult-to-adult 13 transmission after infectious reactivation is the main driver of infection. 14 
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Males Density Antibody concentration U ml assay (-0.8 U/ml), and show that our classification with three components is supported 72 by the data (i.e. has high probability of yielding an informed decision). respectively. In both females and males the latently infected prevalence remains 78 approximately constant, ranging from 0.15 to 0.20 in females and from 0.18 to 0.28 in 79 males. In contrast, the prevalence of persons with increased antibodies increases 80 strongly with age, especially in females. In fact, the prevalence of persons with 81 increased antibodies increases from 0.09 (95%CrI: 0.06-0.13) at 20 years to 0.57 82 (95%CrI: 0.47-0.67) at 80 years in females, and from 0.04 (95%CrI: 0.03-0.07) to 0.37 83 (95%CrI: 0.28-0.46) in males. Hence, in older persons the prevalence of persons with 84 increased antibodies is 54% (or 20 per cent points) higher in females than in males. susceptible; purple: infected); red: infected with increased antibody concentration), and receiver operating characteristic of binary classifications taking the estimated distributions as ground truth (right-hand panel). Maximal sum of sensitivity and specificity (Se+Sp) for classification of uninfected versus infected persons is 1.97 at antibody concentration -0.70 U/ml, with sensitivity 0.99 and specificity 0.98 ( Figure S8 ). This value corresponds well with the threshold for infection of -0.8 U/ml suggested by the supplier of the assay. Maximal Se+Sp for classification of persons with increased antibody concentration is 1.70 at antibody concentration 1.81 U/ml, with sensitivity 0.84 and specificity 0.87 (Fig 8) . estimates of reactivation rates are higher and slightly more precise in the model without year-old girls ( Fig 5) . Owing to the slightly higher contact rates in females than in men, the estimated force of infection is usually a couple percentage points higher in females than in males in the age groups 10-25 years [24] . In older age groups, estimates of the Our study of population-wide serological data shows that IgG antibody concentrations 168 contain a wealth of information on the transmission dynamics of CMV. Specifically, the 169 analyses reveal that (i) the prevalence of CMV increases gradually with age such that at 170 old age the majority of persons in the Netherlands are infected; (ii) except for the very 171 young, prevalence of CMV is systematically higher in females than in males. This is 172 mainly due to a higher incidence of infection in adult women than in adult men of This is caused by the fact that transmissibility of primary infection determines the rate 177 at which age-specific prevalence increases; if transmissibility of primary infection would 178 be high then a high prevalence of infection is expected in children ( Fig 10) . In other 179 words, the fact that seroprevalence increases gradually with age puts an upper bound on The main implication is that the majority of CMV infections may not be caused by infection alone is unlikely to be able to maintain sustained transmission in the 207 population. In fact, further analyses based on the current parameter estimates suggest 208 that primary infection coupled with infectious reactivation would not be sufficient to 209 ensure persistence, as the estimated basic reproduction number is smaller than the 210 threshold value 1 (Methods; Fig 12) . This, in turn, indicates that perinatal transmission 211 is required for persistence.
212
With infectious reactivation and perinatal infection being putative drivers of 213 transmission, it is to be expected that elimination by vaccination may prove more 214 difficult than for directly transmitted pathogens, as it will require the pool of latently we assume that antibody measurements not only give information on CMV infection 237 status, but also whether or not reactivation/re-infection have taken place.
238
Unfortunately, there is no direct empirical evidence available confirming or falsifying 239 this assumption, and this is an area where in-depth comparison of the infection and 240 immune status of persons with low and high antibody concentrations is urgently needed.
241
Third, the analyses assume that person-to-person transmission is proportional to 242 observed human contact patterns (Fig 11; [24 The study was approved by the Medical Ethics Testing Committee of the foundation of transformation, which merely serves to ensure that the data are well-described by 303 Normal mixture distributions (not shown). We distinguish three distributions, show no noticeable improvement in fit when including age by sex interaction (not 323 shown). 324 We estimate parameters in a Bayesian framework using R and JAGS [43, 44] .
325
Non-informative Normal prior distributions are set on the means of the three component 326 distributions (N (0, 0.001)). Label switching is prevented by prior ordering of the means.
327
The precisions of the components are given flat Gamma prior distributions 328 (Γ(0.5, 0.005)). The spline parameters are also given non-informative Normal prior 329 distributions (N (0, 0.001)). We apply a QR-decomposition to the design matrix to 330 improve mixing and run 10 MCMC chains in parallel, yielding a total of 10,000 samples.
331
Although mixing of the unthinned samples is already satisfactory, we apply an 332 additional 1/10 thinning, giving a total of 1,000 samples from the posterior distribution.
Classification i ∈ {♀, ♂}, the age-dependent differential equations are given by conditions, and the solution of (1) is given by
(3)
Insertion of Eq (3) in Eq (2) yields two integral equations for the age-specific forces of 386 infection in females and males [25, 26, 49, 50] . These equations cannot be solved 387 explicitly in general. It is possible, however, to solve the equations for specific functions.
388
Here we assume that transition rates and contact rates are constant on predefined 
where superscripts denoting sex have been dropped for notational convenience. Since subsequently also an estimate of the reactivation rate ρ(a) (if z is assumed known).
402
Notice that these estimates are not necessarily compatible with the transmission model.
403
In particular, the rates so estimated are not necessarily positive (Fig 9) .
404
Assuming that re-infection is negligible (z=0), we find that estimates of the forces of 
where i ∈ {♀, ♂} and B i j = 1 − S i j − L i j . Insertion of Eq (5) in Eq (2) and making use of 426 the fact that the cumulative incidences of infection and reactivation/re-infection in age 427 class j are given by age at the moment of reactivation, due to highly age-assortative mixing patterns 515 (Fig 11) .
516
The above analyses can be generalized and made more precise by using full vital Fig 3) . Thin solid lines show the fit (using the ML parameter estimates) of the transmission model with infectious reactivation and re-infection. Dotted and dashed lines show the fits of the transmission model with no reactivation and with reactivation and re-infection not being infectious, respectively. The fit of the transmission model with infectious reactivation but no re-infection is very close to the fit of the full model with infectious reactivation and infectious re-infection, and is not shown. 
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